Profit After Tax (PAT) for the quarter at Rs 131 crores grew by ~ 13 per cent
Consolidated profit rose to Rs 1.24 billion ($15.22 million) for the three months ended 31st December, from Rs 1.01 billion a year…
The drug firm had reported a net profit of Rs 706 crore in the October-December period of the previous fiscal.
Its total revenue from operations rose to Rs 5,810 crore for the third quarter compared to Rs 5,479 in the year-ago period, Cipla…
The American partner EyeC America contributed to this with an order intake above the €2 million mark